Insights From the PLCO Trial About Prostate Cancer Screening

被引：2
|
作者：
Gulati, Roman [1 ]
Albertsen, Peter C. [2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA
[2] Univ Connecticut, Ctr Hlth, Dept Surg, Div Urol, Farmington, CT USA
来源：
CANCER | 2017年 / 123卷 / 04期
关键词：
RANDOMIZED PROSTATE; MORTALITY; ERSPC;
D O I：
10.1002/cncr.30472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [41] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Catherine A. McCarty
    Douglas J. Reding
    John Commins
    Craig Williams
    Meredith Yeager
    James K. Burmester
    Catherine Schairer
    Regina G. Ziegler
    Breast Cancer Research and Treatment, 2012, 133 : 785 - 792
  • [42] Flexible sigmoidoscopy in the PLCO cancer screening trial: Results from the baseline screening examination of a randomized trial
    Weissfeld, JL
    Schoen, RE
    Pinsky, PF
    Bresalier, RS
    Church, T
    Yurgalevitch, S
    Austin, JH
    Prorok, PC
    Gohagan, JK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (13): : 989 - 997
  • [43] FACTORS INFLUENCING PROSTATE CANCER MORTALITY IN THE PLCO TRIAL
    Crawford, E. David
    Izmirlian, Grant
    Grubb, Robert L., III
    Kramer, Barnett S.
    Church, Timothy R.
    Black, Amanda
    Riley, Thomas M.
    Hickey, Thomas
    Ragard, Lawrence
    Prorok, Philip C.
    Berg, Christine D.
    Andriole, Gerald L.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E224 - E225
  • [44] Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial
    Abdel-Rahman, Omar
    CLINICAL GENITOURINARY CANCER, 2019, 17 (04) : E837 - E844
  • [45] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    McCarty, Catherine A.
    Reding, Douglas J.
    Commins, John
    Williams, Craig
    Yeager, Meredith
    Burmester, James K.
    Schairer, Catherine
    Ziegler, Regina G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 785 - 792
  • [46] Protective Effect of Bisphosphonates on Endometrial Cancer Incidence in Data From the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Hensley, Sharon
    Rattan, Ramandeep
    Buekers, Thomas E.
    Munkarah, Adnan R.
    CANCER, 2015, 121 (03) : 441 - 447
  • [47] Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)
    Heidenreich, A.
    Nitschmann, S.
    INTERNIST, 2010, 51 (02): : 219 - 220
  • [48] Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial
    Prorok, Philip C.
    Wright, Patrick
    Riley, Thomas R.
    Kramer, Barnett S.
    Berg, Christine D.
    Gohagan, John K.
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (04) : 257 - 273
  • [49] Building Successful Relationships in the PLCO Cancer Screening Trial
    Marcus, Pamela M.
    Broski, Karen G.
    Buys, Saundra S.
    Childs, Jeffery
    Church, Timothy R.
    Gohagan, John K.
    Gren, Lisa H.
    Higgins, Darlene
    Jaggi, Rachel
    Jenkins, Victoria
    Johnson, Christine C.
    Lappe, Karen
    O'Brien, Barbara
    Ogden, Sheryl L.
    Prorok, Philip C.
    Reding, Douglas
    Shambaugh, Vicki
    Yokochi, Lance A.
    Yurgalevitch, Susan
    REVIEWS ON RECENT CLINICAL TRIALS, 2015, 10 (03) : 181 - 186
  • [50] Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Hayes, RB
    Reding, D
    Kopp, W
    Subar, AF
    Bhat, N
    Rothman, N
    Caporaso, N
    Ziegler, RG
    Johnson, CC
    Weissfeld, JL
    Hoover, RN
    Hartge, P
    Palace, C
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 349S - 355S
12345